ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,587Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 457

$971K Total Retail Price of All Prescriptions

Rank: 49 out of 457

850 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 850 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 28,130 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,713 1,642 1 2
OMEPRAZOLE 1,264 1,184 2 1
ALPRAZOLAM 979 928 3 39
LEVOTHYROXINE SODIUM 856 798 4 5
ATENOLOL 739 714 5 11
LORAZEPAM 722 683 10 6 87
METFORMIN HCL 703 658 7 6
LISINOPRIL 669 651 8 3
TEMAZEPAM 601 596 9 48
HYDROCHLOROTHIAZIDE 532 519 10 8
VIAGRA 496 456 11 63
LOSARTAN POTASSIUM 493 483 12 18
AMLODIPINE BESYLATE 467 460 13 4
ENALAPRIL MALEATE 431 421 14 35
ATORVASTATIN CALCIUM 399 388 15 33
ALENDRONATE SODIUM 396 387 16 16
TAMSULOSIN HCL 365 344 17 36
RANITIDINE HCL 364 364 18 17
METOPROLOL SUCCINATE 360 348 19 21
METOPROLOL TARTRATE 356 344 20 7
FUROSEMIDE 336 324 21 10
GLYBURIDE 326 326 R 22 64
FENOFIBRATE 322 279 23 46
LOSARTAN-HYDROCHLOROTHIAZIDE 305 305 24 54
CARVEDILOL 303 282 25 20
LOVASTATIN 295 295 26 25
TRAMADOL HCL 292 266 27 26
FAMOTIDINE 283 276 28 62
SERTRALINE HCL 260 241 29 57
ZOLPIDEM TARTRATE 259 241 30 13
JANUVIA 239 234 31 80
FINASTERIDE 238 226 32 85
GLIPIZIDE 237 223 33 42
PAROXETINE HCL 218 199 34 68
WARFARIN SODIUM 215 215 35 38
FLUTICASONE PROPIONATE 213 194 36 40
MECLIZINE HCL 211 211 37 55
CRESTOR 205 193 38 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 192 39 37
CLOPIDOGREL 201 182 40 19
VENTOLIN HFA 196 191 41 96
TRAMADOL HCL-ACETAMINOPHEN 186 176 42 134
DIGOXIN 182 182 43 69
IBUPROFEN 180 164 44 14
GABAPENTIN 175 164 45 15
DONEPEZIL HCL 173 173 46 22
FLUOXETINE HCL 169 169 47 108
NAMENDA 166 159 48 32
MEGESTROL ACETATE 166 166 R 48 94
PRAVASTATIN SODIUM 162 155 50 29
CITALOPRAM HBR 161 154 51 45
DOXAZOSIN MESYLATE 152 140 52 73
BACLOFEN 151 119 53 141
PROAIR HFA 149 144 54 66
VOLTAREN 145 138 55 34
AMLODIPINE BESYLATE-BENAZEPRIL 142 137 56 72
PLAVIX 140 131 57 24
PANTOPRAZOLE SODIUM 140 133 57 59
METOCLOPRAMIDE HCL 133 129 59 116
ADVAIR DISKUS 129 122 60 27
DICLOFENAC SODIUM 119 110 61 49
ISOSORBIDE MONONITRATE ER 118 118 62 84
ATENOLOL-CHLORTHALIDONE 116 112 63 208
EASY TOUCH 115 111 64 231
FELODIPINE ER 114 114 65 249
GEMFIBROZIL 111 111 66 112
ESCITALOPRAM OXALATE 110 95 67 61
CLOBETASOL PROPIONATE 110 108 67 125
TRIAMTERENE-HCTZ 109 109 69 120
VERAPAMIL ER 107 107 70 145
LEVOCETIRIZINE DIHYDROCHLORIDE 106 98 71 317
ALLOPURINOL 101 101 72 47
PENTOXIFYLLINE 97 94 73 67
GLYBURIDE-METFORMIN HCL 96 91 R 74 70
RISPERIDONE 95 81 75 102
POTASSIUM CHLORIDE 94 94 76 28
DIOVAN 93 81 77 30
HYDROCODONE-ACETAMINOPHEN 92 69 S3 78 23
TRAZODONE HCL 92 62 78 104
OXYBUTYNIN CHLORIDE ER 87 81 80 195
CLONIDINE HCL 86 82 81 52
LANSOPRAZOLE 86 82 81 74
AGGRENOX 84 84 83 210
MELOXICAM 81 66 84 41
CICLOPIROX 80 78 85 126
NIFEDIPINE ER 79 79 86 89
NEXIUM 77 74 87 12
LANTUS 77 74 87 56
CILOSTAZOL 76 66 89 88
BUSPIRONE HCL 74 67 90 170
KETOCONAZOLE 73 73 91 92
QUETIAPINE FUMARATE 70 63 92 109
BUMETANIDE 68 68 93 123
SYNTHROID 68 63 93 93
NITROSTAT 67 65 95 167
NYSTATIN-TRIAMCINOLONE 67 59 95 200
INDAPAMIDE 67 63 95 423
PREDNISONE 66 66 98 95
CARBIDOPA-LEVODOPA 65 65 99 128
CLOTRIMAZOLE-BETAMETHASONE 65 61 99 60
GLIMEPIRIDE 64 64 101 75
DILTIAZEM ER 64 64 101 217
POLYETHYLENE GLYCOL 3350 62 56 103 187
SINGULAIR 62 62 103 43
TERAZOSIN HCL 61 61 105 180
AMITRIPTYLINE HCL 61 58 R 105 156
HUMULIN 70-30 60 54 107 203
BENICAR 59 59 108 90
CHLORDIAZEPOXIDE HCL 58 53 109 233
SEROQUEL 58 56 109 182
DOXEPIN HCL 57 57 111 437
BETAMETHASONE VALERATE 56 53 112 339
BENAZEPRIL HCL 55 55 113 114
SPIRONOLACTONE 55 55 113 124
NAPROXEN 54 50 115 65
PROPRANOLOL HCL 54 53 115 176
GALANTAMINE HBR 54 54 115 194
DOXYCYCLINE HYCLATE 51 49 118 241
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.